Skip to content
★ Sign in to follow
ED

Eric David

VivoSim Labs, Inc.
Total declarations
16
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (7 ops.)
€790k

Latest filing published 16 Nov 2017 for VivoSim Labs, INC., €7,012.

Insider track record

Disclosed buys
0
Disclosed sells
7
Signal history

Eric David: trading record in brief

This profile gathers the share dealings of Eric David in VivoSim Labs, Inc. In total, 16 filings cover trades dated from 7 October 2013 to 16 November 2017.

On the market, this insider has only sold: 7 sales, €790k in total. The rest of the record consists of 9 share grants.

The latest filing, published on 16 November 2017, reports a share grant of €7,012 in VivoSim Labs, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Eric David

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total
  • ◆
    CSO & EVP Pre-Clinical DevExecutivesVivoSim Labs, Inc.
    8,269 USD13SEC
    5,625 shares@ US$1.4724.2% of flowCommon StockSEC:0001209191-17-061324:0
  • ◆
    CSO & EVP Pre-Clinical DevExecutivesVivoSim Labs, Inc.
    17,446 USD16SEC
    8,469 shares@ US$2.0651.2% of flowCommon StockSEC:0001209191-17-049422:0
  • ◆
    CSO & EVP Pre-Clinical DevExecutivesVivoSim Labs, Inc.
    0SEC
    190,000 shares0Common StockSEC:0001209191-17-042350:0
  • ◆
    CSO & EVP Pre-Clinical DevExecutivesVivoSim Labs, Inc.
    3,612 USD12SEC
    1,263 shares@ US$2.8611.2% of flowCommon StockSEC:0001209191-17-033415:0
  • ◆
    CSO & EVP Pre-Clinical DevExecutivesVivoSim Labs, Inc.
    4,101 USD12SEC
    1,390 shares@ US$2.9513.4% of flowCommon StockSEC:0001209191-17-012847:0
  • ◆
    CSO & EVP Pre-Clinical DevExecutivesVivoSim Labs, Inc.
    5,689 USD0SEC
    1,745 shares@ US$3.26Common StockSEC:0001209191-16-151268:0
  • ◆
    CSO & EVP Pre-Clinical DevExecutivesVivoSim Labs, Inc.
    4,820 USD0SEC
    1,205 shares@ US$4.00Common StockSEC:0001209191-16-138413:0
  • ▼
    CSO & EVP Pre-Clinical DevExecutivesVivoSim Labs, Inc.
    91,000 USD0SEC
    20,000 shares@ US$4.55Common StockSEC:0001209191-16-136190:0
  • ◆
    CSO & EVP Pre-Clinical DevExecutivesVivoSim Labs, Inc.
    0SEC
    50,000 shares0Common StockSEC:0001209191-16-132647:0
  • ▼
    Chief Strategy OfficerExecutivesVivoSim Labs, Inc.
    27,750 USD0SEC
    3,700 shares@ US$7.50Common StockSEC:0001181431-14-039927:0
  • ▼
    Chief Strategy OfficerExecutivesVivoSim Labs, Inc.
    123,228 USD0SEC
    16,300 shares@ US$7.56Common StockSEC:0001181431-14-039927:1
  • ▼
    Chief Strategy OfficerExecutivesVivoSim Labs, Inc.
    219,000 USD0SEC
    30,000 shares@ US$7.30Common StockSEC:0001181431-14-032163:0
  • ▼
    Chief Strategy OfficerExecutivesVivoSim Labs, Inc.
    171,123 USD0SEC
    16,470 shares@ US$10.39Common StockSEC:0001181431-13-059343:0
  • ◆
    Chief Strategy OfficerExecutivesVivoSim Labs, Inc.
    20,000 USD0SEC
    20,000 shares@ US$1.00Common StockSEC:0001181431-13-053881:0
  • ▼
    Chief Strategy OfficerExecutivesVivoSim Labs, Inc.
    19,980 USD0SEC
    3,530 shares@ US$5.66Common StockSEC:0001181431-13-053881:1
  • ▼
    Chief Strategy OfficerExecutivesVivoSim Labs, Inc.
    369,180 USD0SEC
    63,000 shares@ US$5.86Common StockSEC:0001181431-13-053380:0

16 of 16 declarations